Regeneron, Sanofi Test The Public's Cholesterol IQ To Prep For Alirocumab Launch

Have You Been Counted? Regeneron And Sanofi US Join Forces With Leading Cardiovascular Organizations To Raise Awareness Of Cholesterol New program will spotlight America's high cholesterol numbersVisit CholesterolCounts.com to take a brief poll and learn more TARRYTOWN, N.Y. and BRIDGEWATER, N.J., Dec. 15, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. and Sanofi US are collaborating with nationally-recognized patient and professional heart disease organizations to launch Cholesterol Counts, an awareness program that will gauge how much Americans know about cholesterol, their numbers, and the risks associated with high LDL-C .

http://ift.tt/1wF0sDU